icad inc. (NASDAQ:ICAD) headquartered in Nashua, will host a conference call for the investment community to discuss the 3Q20 financial results on 5th November 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.icadmed.com
Earnings Expectation
icad inc. is set to announce third quarter earning results on Thursday 5th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, ICAD to report 3Q20 loss of $ 0.11 per share. For the full year, analysts anticipate top line of $ 26.31 million, while looking forward to loss of $ 0.47 per share bottom line.
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy.
